Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 16/20 | 0.51 |
| ▸ | MAPK14 | Q16539 | 7/20 | 0.51 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.51 |
| ▸ | HCK | P08631 | 1/20 | 0.51 |
| ▸ | SRC | P12931 | 1/20 | 0.51 |
| ▸ | JAK3 | P52333 | 1/20 | 0.51 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.51 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31704600 | 1.00 | LCK (0.51) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31052513 | 0.90 | LCK (0.50) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31705717 | 0.88 | LCK (0.45) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31705998 | 0.87 | LCK (0.43) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31704463 | 0.87 | LCK (0.69) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31052467 | 0.85 | LCK (0.49) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31052442 | 0.84 | LCK (0.44) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31705616 | 0.84 | LCK (0.48) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31052616 | 0.83 | MAPK14 (0.47) | LCKMAPK14MAPK13EGFRFYN | |
| SCHEMBL31052490 | 0.83 | LCK (0.43) | LCKMAPK14MAPK13EGFRFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025215187-A1 | THERAPEUTIC COMPOUNDS AND THEIR USE | MY-T BIO LIMITED (GB) | 2025-10-16 | — | — | WO | disclosed |